Pharmaceuticals

2 articles

Microscopic view of Survodutide drug molecules precisely targeting and reducing visceral and liver fat cells within the human body.

Survodutide drug slashes visceral and liver fat in trials

In a recent trial, Survodutide slashed liver fat by 62% in just 24 weeks, a reduction so rapid it outpaced overall weight loss, according to emerging data suggest survodutide targets liver fat more ra

Elena Pappas·June 8, 2026

Diverse individuals celebrating significant weight loss and body fat reduction achieved with new GLP-1 medications, symbolizing hope and scientific advancement.

Hypertrophy Hub

New Drugs Help Patients Lose 60 Pounds and 30% Body Fat

One year ago, Sarah struggled to lose 10 pounds.

Elena Pappas·May 24, 2026